Fatty acid transport across the cell membrane: Regulation by fatty acid transporters

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 4-6, 2010, Pages 149-154

  Schwenk, Robert W ^a   Holloway, Graham P ^b   Luiken, Joost J F P ^a   Bonen, Arend ^b   Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 1; FATTY ACID TRANSPORTER 4; GLUCOSE TRANSPORTER 4; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CELL MIGRATION; ESTERIFICATION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE OVEREXPRESSION; GENE TRANSLOCATION; HEART MUSCLE; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; MUSCLE CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; CELL MEMBRANE; FATTY ACID TRANSPORT PROTEINS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MICE; MODELS, BIOLOGICAL; MUSCLES; RATS;

EID: 77951976294     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.029     Document Type: Article

References (59)

1. Vorum H., Brodersen R., Kragh-Hansen U., Pedersen A.O. Solubility of long-chain fatty acids in phosphate buffer at pH 7.4. Biochim. Biophys. Acta 1992, 1126(2):135-142.
2. Richieri G.V., Anel A., Kleinfeld A.M. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 1993, 32(29):7574-7580.
3. Vork M.M., Glatz J.F., Van Der Vusse G.J. On the mechanism of long chain fatty acid transport in cardiomyocytes as facilitated by cytoplasmic fatty acid-binding protein. J. Theor. Biol. 1993, 160(2):207-222.
4. Richieri G.V., Ogata R.T., Kleinfeld A.M. Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J. Biol. Chem. 1994, 269(39):23918-23930.
5. Richieri G.V., Kleinfeld A.M. Unbound free fatty acid levels in human serum. J. Lipid Res. 1995, 36(2):229-240.
6. Luiken J.J., Koonen D.P., Coumans W.A., et al. Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice. Lipids 2003, 38(4):491-496.
7. Kampf J.P., Kleinfeld A.M. Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda) 2007, 22:7-14.
8. Bonen A., Chabowski A., Luiken J.J., Glatz J.F. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) 2007, 22:15-29.
9. Kamp F., Hamilton J.A. pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. Proc. Natl. Acad. Sci. USA 1992, 89(23):11367-11370.
10. Kamp F., Hamilton J.A. How fatty acids of different chain length enter and leave cells by free diffusion. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75(3):149-159.
11. Hamilton J.A. New insights into the roles of proteins and lipids in membrane transport of fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77(5-6):355-361.
12. Glatz J.F., Luiken J.J., Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol. Rev. 2010, 90:367-417.
13. Clarke D.C., Miskovic D., Han X.X., et al. Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol. Genomics 2004, 17(1):31-37.
14. Nickerson J.G., Alkhateeb H., Benton C.R., et al. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J. Biol. Chem. 2009, 284(24):16522-16530.
15. Bonen A., Luiken J.J., Arumugam Y., Glatz J.F., Tandon N.N. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 2000, 275(19):14501-14508.
16. Luiken J.J., Koonen D.P., Willems J., et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 2002, 51(10):3113-3119.
17. Luiken J.J., Coort S.L., Willems J., et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003, 52(7):1627-1634.
18. Luiken J.J., Willems J., van der Vusse G.J., Glatz J.F. Electrostimulation enhances FAT/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes. Am. J. Physiol. Endocrinol. Metab. 2001, 281(4):E704-E712.
19. Karlsson H.K., Chibalin A.V., Koistinen H.A., et al. Kinetics of GLUT4 trafficking in rat and human skeletal muscle. Diabetes 2009, 58(4):847-854.
20. van Oort M.M., van Doorn J.M., Bonen A., et al. Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. Biochim. Biophys. Acta 2008, 1781(1-2):61-71.
21. Turcotte L.P., Raney M.A., Todd M.K. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle. Acta Physiol. Scand. 2005, 184(2):131-139.
22. Jain S.S., Chabowski A., Snook L.A., et al. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters FAT/CD36, FABPpm, FATP1, 4 and 6. FEBS Lett. 2009, 583(13):2294-2300.
23. Habets D.D., Coumans W.A., Voshol P.J., et al. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem. Biophys. Res. Commun. 2007, 355(1):204-210.
24. Holloway G.P., Jain S.S., Bezaire V.S., et al. FAT/CD36 null mice reveal that mitochondrial FAT/CD36 is required to up-regulate mitochondrial fatty acid oxidation in contracting muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297(4):R960-R967.
25. Luiken J.J., Coort S.L., Willems J., Coumans W.A., Bonen A., Glatz J.F. Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4. Mol. Pharmacol. 2004, 65(3):639-645.
26. Luiken J.J., Momken I., Habets D.D., et al. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling. Endocrinology 2006, 147(11):5205-5216.
27. Schwenk R.W., Luiken J.J., Bonen A., Glatz J.F. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc. Res. 2008, 79(2):249-258.
28. Campbell S.E., Tandon N.N., Woldegiorgis G., Luiken J.J., Glatz J.F., Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J. Biol. Chem. 2004, 279(35):36235-36241.
29. Bezaire V., Bruce C.R., Heigenhauser G.J., et al. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am. J. Physiol. Endocrinol. Metab. 2006, 290(3):E509-E515.
30. Sebastian D., Guitart M., Garcia-Martinez C., et al. Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells. J. Lipid Res. 2009.
31. Holloway G.P., Bezaire V., Heigenhauser G.J., et al. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J. Physiol. 2006, 571(Part 1):201-210.
32. Schwenk R.W., Luiken J.J., Eckel J. FIP2 and Rip11 specify Rab11a-mediated cellular distribution of GLUT4 and FAT/CD36 in H9c2-hIR cells. Biochem. Biophys. Res. Commun. 2007, 363(1):119-125.
33. Eguez L., Lee A., Chavez J.A., et al. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2005, 2(4):263-272.
34. Sano H., Eguez L., Teruel M.N., et al. Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell. Metab. 2007, 5(4):293-303.
35. Ishikura S., Bilan P.J., Klip A. Rabs 8A and 14 are targets of the insulin-regulated Rab-GAP AS160 regulating GLUT4 traffic in muscle cells. Biochem. Biophys. Res. Commun. 2007, 353(4):1074-1079.
36. Kramer H.F., Witczak C.A., Fujii N., et al. Distinct signals regulate AS160 phosphorylation in response to insulin AICAR, and contraction in mouse skeletal muscle. Diabetes 2006, 55(7):2067-2076.
37. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 2006, 7(9):631-643.
38. Sevilla L., Tomas E., Munoz P., et al. Characterization of two distinct intracellular GLUT4 membrane populations in muscle fiber. Differential protein composition and sensitivity to insulin. Endocrinology 1997, 138(7):3006-3015.
39. Kawanishi M., Tamori Y., Okazawa H., Araki S., Shinoda H., Kasuga M. Role of SNAP23 in insulin-induced translocation of GLUT4 in 3T3-L1 adipocytes. Mediation of complex formation between syntaxin4 and VAMP2. J. Biol. Chem. 2000, 275(11):8240-8247.
40. Tamori Y., Kawanishi M., Niki T., et al. Inhibition of insulin-induced GLUT4 translocation by Munc18c through interaction with syntaxin4 in 3T3-L1 adipocytes. J. Biol. Chem. 1998, 273(31):19740-19746.
41. Fukuda N., Emoto M., Nakamori Y., et al. DOC2B: a novel syntaxin-4 binding protein mediating insulin-regulated GLUT4 vesicle fusion in adipocytes. Diabetes 2009, 58(2):377-384.
42. Boden G., Chen X., Iqbal N. Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 1998, 47(10):1609-1612.
43. Pan D.A., Lillioja S., Kriketos A.D., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46(6):983-988.
44. Unger R.H. Lipotoxic diseases. Annu. Rev. Med. 2002, 53:319-336.
45. Holland W.L., Knotts T.A., Chavez J.A., Wang L.P., Hoehn K.L., Summers S.A. Lipid mediators of insulin resistance. Nutr. Rev. 2007, 65(6, Part 2):S39-S46.
46. Luiken J.J., Arumugam Y., Dyck D.J., et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 2001, 276(44):40567-40573.
47. Coort S.L., Hasselbaink D.M., Koonen D.P., et al. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes 2004, 53(7):1655-1663.
48. Ouwens D.M., Diamant M., Fodor M., et al. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 2007, 50(9):1938-1948.
49. Holloway G.P., Benton C.R., Mullen K.L., et al. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am. J. Physiol. Endocrinol. Metab. 2009, 296(4):E738-E747.
50. Bonen A., Parolin M.L., Steinberg G.R., et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 2004, 18(10):1144-1146.
51. Glatz J.F., Bonen A., Ouwens D.M., Luiken J.J. Regulation of sarcolemmal transport of substrates in the healthy and diseased heart. Cardiovasc. Drugs Ther. 2006, 20(6):471-476.
52. Su X., Abumrad N.A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metab. 2009, 20(2):72-77.
53. Doege H., Stahl A. Protein-mediated fatty acid uptake: novel insights from in vivo models. Physiology (Bethesda) 2006, 21:259-268.
54. Febbraio M., Silverstein R.L. CD36: implications in cardiovascular disease. Int. J. Biochem. Cell Biol. 2007, 39(11):2012-2030.
55. Yang J., Sambandam N., Han X., et al. CD36 deficiency rescues lipotoxic cardiomyopathy. Circ. Res. 2007, 100(8):1208-1217.
56. Mitchell R.W., Edmundson C.L., Miller D.W., Hatch G.M. On the mechanism of oleate transport across human brain microvessel endothelial cells. J. Neurochem. 2009, 110(3):1049-1057.
57. Owada Y. Fatty acid binding protein: localization and functional significance in the brain. Tohoku J. Exp. Med. 2008, 214(3):213-220.
58. Glatz J.F., Storch J. Unravelling the significance of cellular fatty acid-binding proteins. Curr. Opin. Lipidol. 2001, 12(3):267-274.
59. Storch J., Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu. Rev. Nutr. 2008, 28:73-95.